Literature DB >> 29763549

Development of Positron Emission Tomography Radiotracers for the GABA Transporter 1.

Alexandra R Sowa1,2, Allen F Brooks1, Xia Shao1, Bradford D Henderson1, Philip Sherman1, Janna Arteaga1, Jenelle Stauff1, Adam C Lee3, Robert A Koeppe1, Peter J H Scott1,2, Michael R Kilbourn1.   

Abstract

In vivo positron emission tomography (PET) imaging of the γ-aminobutyric acid (GABA) receptor complex has been accomplished using radiolabeled benzodiazepine derivatives, but development of specific presynaptic radioligands targeting the neuronal membrane GABA transporter type 1 (GAT-1) has been less successful. The availability of new structure-activity studies of GAT-1 inhibitors and the introduction of a GAT-1 inhibitor (tiagabine, Gabatril) into clinical use prompted us to reinvestigate the syntheses of PET ligands for this transporter. Initial synthesis and rodent PET studies of N-[11C]methylnipecotic acid confirmed the low brain uptake of that small and polar molecule. The common design approach to improve blood-brain barrier permeability of GAT-1 inhibitors is the attachment of a large lipophilic substituent. We selected an unsymmetrical bis-aromatic residue attached to the ring nitrogen by a vinyl ether spacer from a series recently reported by Wanner and coworkers. Nucleophilic aromatic substitution of an aryl chloride precursor with [18F]fluoride was used to prepare the desired candidate radiotracer ( R, E/ Z)-1-(2-((4-fluoro-2-(4-[18F]fluorobenzoyl)styryl)oxy)ethyl)piperidine-3-carboxylic acid (( R, E/ Z)-[18F]10). PET studies in rats showed no brain uptake, which was not altered by pretreatment of animals with the P-glycoprotein inhibitor cyclosporine A, indicating efflux by Pgp was not responsible. Subsequent PET imaging studies of ( R, E/ Z)-[18F]10 in rhesus monkey brain showed very low brain uptake. Finally, to test if the free carboxylic acid group was the likely cause of poor brain uptake, PET studies were done using the ethyl ester derivative of ( R, E/ Z)-[18F]10. Rapid and significant monkey brain uptake of the ester was observed, followed by a slow washout over 90 min. The blood-brain barrier permeability of the ester supports a hypothesis that the free acid function limits brain uptake of nipecotic acid-based GAT-1 radioligands, and future radiotracer efforts should investigate the use of carboxylic acid bioisosteres.

Entities:  

Keywords:  GABA; fluorine-18; positron emission tomography; transporter

Mesh:

Substances:

Year:  2018        PMID: 29763549      PMCID: PMC6249062          DOI: 10.1021/acschemneuro.8b00183

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  42 in total

1.  Synthesis, stability, and pharmacological evaluation of nipecotic acid prodrugs.

Authors:  F P Bonina; L Arenare; F Palagiano; A Saija; F Nava; D Trombetta; P de Caprariis
Journal:  J Pharm Sci       Date:  1999-05       Impact factor: 3.534

2.  Increased [(3)H]tiagabine binding to GAT-1 in the cingulate cortex in schizophrenia.

Authors:  Ingrid Sundman-Eriksson; Kaj Blennow; Pia Davidsson; Anna-Karin Dandenell; Jan Marcusson
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

3.  Generation and screening of oxime libraries addressing the neuronal GABA transporter GAT1.

Authors:  Felix T Kern; Klaus T Wanner
Journal:  ChemMedChem       Date:  2014-11-04       Impact factor: 3.466

4.  Age-correlated decline in [3H]tiagabine binding to GAT-1 in human frontal cortex.

Authors:  Ingrid Sundman-Eriksson; Per Allard
Journal:  Aging Clin Exp Res       Date:  2006-06       Impact factor: 3.636

5.  The pharmacokinetic inter-relationship of tiagabine in blood, cerebrospinal fluid and brain extracellular fluid (frontal cortex and hippocampus).

Authors:  Xiaolan Wang; Neville Ratnaraj; Philip N Patsalos
Journal:  Seizure       Date:  2004-12       Impact factor: 3.184

6.  (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier.

Authors:  C Braestrup; E B Nielsen; U Sonnewald; L J Knutsen; K E Andersen; J A Jansen; K Frederiksen; P H Andersen; A Mortensen; P D Suzdak
Journal:  J Neurochem       Date:  1990-02       Impact factor: 5.372

7.  Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.

Authors:  Gabriele Quandt; Georg Höfner; Klaus T Wanner
Journal:  Bioorg Med Chem       Date:  2013-04-02       Impact factor: 3.641

Review 8.  A novel selective gamma-aminobutyric acid transport inhibitor demonstrates a functional role for GABA transporter subtype GAT2/BGT-1 in the CNS.

Authors:  Rasmus P Clausen; Bente Frølund; Orla M Larsson; Arne Schousboe; Povl Krogsgaard-Larsen; H Steve White
Journal:  Neurochem Int       Date:  2006-03-03       Impact factor: 3.921

9.  gamma-Aminobutyric acid uptake inhibition and anticonvulsant activity of nipecotic acid esters.

Authors:  A M Crider; J D Wood; K D Tschappat; C N Hinko; K Seibert
Journal:  J Pharm Sci       Date:  1984-11       Impact factor: 3.534

10.  Structure Property Relationships of Carboxylic Acid Isosteres.

Authors:  Pierrik Lassalas; Bryant Gay; Caroline Lasfargeas; Michael J James; Van Tran; Krishna G Vijayendran; Kurt R Brunden; Marisa C Kozlowski; Craig J Thomas; Amos B Smith; Donna M Huryn; Carlo Ballatore
Journal:  J Med Chem       Date:  2016-03-30       Impact factor: 7.446

View more
  1 in total

Review 1.  Classics in Neuroimaging: Development of Positron Emission Tomography Tracers for Imaging the GABAergic Pathway.

Authors:  Emily Murrell; Jonathan M Pham; Alexandra R Sowa; Allen F Brooks; Michael R Kilbourn; Peter J H Scott; Neil Vasdev
Journal:  ACS Chem Neurosci       Date:  2020-06-24       Impact factor: 4.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.